Prestige® V+VEE With Havlogen®*
Eastern, Western and Venezuelan, Killed Virus
A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin, Equine Encephalomyelitis Virus, Eastern, Western, and Venezuelan, Equine Herpesviruse EHV-1 and EHV-4, Equine Influenza Virus subypes A1 and A2 including KY93 strain, and Tetanus Toxoid. Intervet serological data suggest Influenza cross protection against certain U.S. and European strains, including Kentucky 93, 94, 95 and 96, Suffolk 89, Kildare 89 and 92, Austria 92, Switzerland 93, New Market 1-93, and 2-93, Berlin 94, italy 96 and Meath 96.**
Indications: For vaccination of healthy horses against Eastern, Western and Venezuelan Encephalomyelitis, Equine Herpesvirus and Equine Influenza Virus.
Dose: For primary immunization aseptically inject 1 mL intramuscularly and repeat the does in 3 to 4 weeks. A 1 mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.
Caution: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only.
Anaphylactoid reactions may occur.
Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.
*Adjuvant-Intervet's Proprietary Technology
**Data available upon request.
FOR USE IN ANIMALS ONLY
P.O. Box 75612
Charlotte, NC 28275